SCHEMBL8445470

SCHEMBL8445470

CSc1cc(-c2ccccc2)nc2c1C(=O)N(C(=O)OC(C)(C)C)C(C)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.36
USP30 Q70CQ3 2/20 0.36
UCHL1 P09936 1/20 0.35
ACACB O00763 4/20 0.35
ACACA Q13085 1/20 0.35
GPR119 Q8TDV5 2/20 0.35
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34
SKP2 Q13309 1/20 0.34
ADORA1 P30542 2/20 0.34
ADORA2A P29274 1/20 0.34
KLK7 P49862 1/20 0.34
PDE4B Q07343 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
SCN9A Q15858 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1746280 0.88 ADORA1 (0.38) ADORA1ADORA2APDE4BLMNATP53
SCHEMBL8442661 0.84 ACACB (0.38) ABCB1USP30ACACBACACAGPR119
SCHEMBL8443924 0.81 BUB1 (0.44) ABCB1USP30UCHL1ACACBACACA
SCHEMBL8444864 0.78 USP30 (0.37) ABCB1USP30UCHL1ACACBACACA
SCHEMBL8442660 0.72 USP30 (0.39) USP30UCHL1PDE4B
SCHEMBL8446562 0.71 PDE4B (0.41) USP30ADORA1ADORA2APDE4BLMNA
SCHEMBL1746373 0.70 PDE4B (0.39) USP30ADORA1ADORA2APDE4BALDH1A1
SCHEMBL8442662 0.69 BUB1 (0.37) GPR119PDE4BSCN9AALDH1A1
SCHEMBL1746529 0.67 ADORA1 (0.38) ADORA1ADORA2APDE4BLMNAALDH1A1
SCHEMBL6080636 0.66 KLK7 (0.41) USP30GPR119CKS1BSKP1SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380890-A1 New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors Almirall, S.A. (ES) 2011-10-26 EP disclosed